191 related articles for article (PubMed ID: 2674077)
1. Total body irradiation in acute myeloid leukemia and chronic myelogenous leukemia: influence of dose and dose-rate on leukemia relapse.
Scarpati D; Frassoni F; Vitale V; Corvo R; Franzone P; Barra S; Guenzi M; Orsatti M
Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):547-52. PubMed ID: 2674077
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate.
Fyles GM; Messner HA; Lockwood G; Curtis JE; Rider W; Minden MD; Meharchand JM; Lipton J; Tritchler D; Van Dyk J
Bone Marrow Transplant; 1991 Dec; 8(6):453-63. PubMed ID: 1790425
[TBL] [Abstract][Full Text] [Related]
3. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
[TBL] [Abstract][Full Text] [Related]
4. Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels.
Demirer T; Buckner CD; Appelbaum FR; Lambert K; Bensinger WI; Clift R; Storb R; Slattery JT
Bone Marrow Transplant; 1996 Mar; 17(3):341-6. PubMed ID: 8704684
[TBL] [Abstract][Full Text] [Related]
5. The effect of total body irradiation dose and chronic graft-versus-host disease on leukaemic relapse after allogeneic bone marrow transplantation.
Frassoni F; Scarpati D; Bacigalupo A; Vitale V; Corvo R; Miceli S; Gualandi F; Occhini D; Clavio M; van Lint MT
Br J Haematol; 1989 Oct; 73(2):211-6. PubMed ID: 2684259
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK
Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007
[TBL] [Abstract][Full Text] [Related]
7. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
Belkacémi Y; Ozsahin M; Rio B; Laporte JP; Leblond V; Pène F; Laugier A
Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791
[TBL] [Abstract][Full Text] [Related]
8. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia.
Hirabayashi N; Goto S; Ishii M; Yuge M; Mitsuma A; Noda N
Bone Marrow Transplant; 1998 Jun; 21(11):1079-83. PubMed ID: 9645568
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.
Hallemeier C; Girgis M; Blum W; Brown R; Khoury H; Goodnough LT; Vij R; Devine S; Wehde M; Postma S; Lin HS; Dipersio J; Adkins D
Biol Blood Marrow Transplant; 2004 May; 10(5):310-9. PubMed ID: 15111930
[TBL] [Abstract][Full Text] [Related]
10. Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiation.
Ozsahin M; Belkacémi Y; Pène F; Laporte J; Rio B; Leblond V; Korbas D; Touboul E; Gorin NC; Schlienger M; Laugier A
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):71-7. PubMed ID: 12118567
[TBL] [Abstract][Full Text] [Related]
11. Low-dose total body irradiation and G-CSF without hematopoietic stem cell support in the treatment of relapsed or refractory acute myelogenous leukemia (AML), or AML in second or subsequent remission.
Shulman LN; Tarbell NJ; Storen E; Marcus K; Mauch PM
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1113-7. PubMed ID: 9869237
[TBL] [Abstract][Full Text] [Related]
12. High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia.
Kantarjian HM; Talpaz M; Andersson B; Khouri I; Giralt S; Rios MB; Champlin R; Hester J; Deisseroth AB
Bone Marrow Transplant; 1994 Jul; 14(1):57-61. PubMed ID: 7951120
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiation.
Dimopoulos MA; Yau JC; Huan SD; Jagannath S; Spitzer G; Spinolo JA; Zagars GK; LeMaistre CF; Dicke KA; Zander AR
Am J Hematol; 1994 Jun; 46(2):82-6. PubMed ID: 8172200
[TBL] [Abstract][Full Text] [Related]
14. Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autologous cells.
Talpaz M; Kantarjian H; Liang J; Calvert L; Hamer J; Tibbits P; Durett A; Claxton D; Giralt S; Khouri I
Blood; 1995 Jun; 85(11):3257-63. PubMed ID: 7756658
[TBL] [Abstract][Full Text] [Related]
15. Successful pregnancy following very high-dose total body irradiation (1575 cGy) and bone marrow transplantation in a woman with acute myeloid leukemia.
Wang WS; Tzeng CH; Hsieh RK; Chiou TJ; Liu JH; Yen CC; Chen PM
Bone Marrow Transplant; 1998 Feb; 21(4):415-7. PubMed ID: 9509978
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of allogeneic bone marrow transplantation in patients with acute leukemia in complete remission and in patients with chronic myeloid leukemia during the chronic phase].
Liubimova LS; Savchenko VG; Mendeleeva LP; Kliasova GA; Gribanova EO; Demidova IA; Gal'tseva IV; Kuz'mina LA; Momotiuk KS; Kuliev RG
Ter Arkh; 1999; 71(7):27-32. PubMed ID: 10481864
[TBL] [Abstract][Full Text] [Related]
17. High-energy total body irradiation as preparation for bone marrow transplantation in leukemia patients: treatment technique and related complications.
Bradley J; Reft C; Goldman S; Rubin C; Nachman J; Larson R; Hallahan DE
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):391-6. PubMed ID: 9457826
[TBL] [Abstract][Full Text] [Related]
18. Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation.
Matthews DC; Appelbaum FR; Eary JF; Fisher DR; Durack LD; Bush SA; Hui TE; Martin PJ; Mitchell D; Press OW
Blood; 1995 Feb; 85(4):1122-31. PubMed ID: 7849300
[TBL] [Abstract][Full Text] [Related]
19. [Dose-reduced conditioning before allogeneic stem cell transplantation: principles, clinical protocols and preliminary results].
Schmid C; Weisser M; Ledderose G; Stötzer O; Schleuning M; Kolb HJ
Dtsch Med Wochenschr; 2002 Oct; 127(42):2186-92. PubMed ID: 12397547
[TBL] [Abstract][Full Text] [Related]
20. Hyperfractionated total body irradiation for bone marrow transplantation. Results in seventy leukemia patients with allogeneic transplants.
Shank B; Chu FC; Dinsmore R; Kapoor N; Kirkpatrick D; Teitelbaum H; Reid A; Bonfiglio P; Simpson L; O'Reilly RJ
Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1607-11. PubMed ID: 6358154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]